Brief: Vyne Therapeutics Reports Q2 2022 Financial Results

YARROW BIOSCIENCE

12/08/2022 13:27

Aug 12 (Reuters) - Vyne Therapeutics Inc  VYNE.O :
    * VYNE THERAPEUTICS REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS
    * Q2 REVENUE $100,000
    * AS OF JUNE 30, 2022, VYNE HAD CASH AND CASH EQUIVALENTS OF
$42.8
MILLION
    * CURRENTLY ANTICIPATES CASH AND CASH EQUIVALENTS AS OF JUNE
30,
2022 WILL BE SUFFICIENT TO FUND ITS OPERATIONS INTO Q3 OF 2023
    * QTRLY LOSS PER SHARE BASIC AND DILUTED$0.15

Source text for Eikon:  ID:nGNX1d6LSt 
Further company coverage:  VYNE.O 

 (Reporting by Khushi Mandowara)
 ((Khushi.Mandowara@thomsonreuters.com;))